Table 2 Evolution of the data after the intervention in each population
| Â | Breast cancer group | |||||||
|  | Treatment group (N = 68) | Control group (N = 24) | ||||||
| Â | T0 | T1 | Evolution (T0-T1) | Effect size | T0 | T1 | Evolution (T0-T1) | Effect size |
|  | Mean (SD) | Mean (SD) | p | Cohen’s d | Mean (SD) | Mean (SD) | p | Cohen’s d |
HADS – Anxiety | 8.76 (4.14) | 6.70 (3.58) | .000 | 0.66 | 7.17 (2.96) | 7.58 (3.40) | .916 | −0.13 |
HADS - Depression | 5.02 (3.16) | 3.84 (3.01) | .001 | 0.47 | 4.13 (3.72) | 4.04 (3.00) | .999 | 0.04 |
EORTC – Global Health Status | 59.19 (16.23) | 65.40 (15.83) | .020 | −0.38 | 56.94 (20.21) | 58.33 (19.19) | .980 | −0.07 |
EORTC – Fatigue | 52.94 (26.05) | 44.77 (21.72) | .003 | 0.41 | 51.85 (30.68) | 46.30 (25.94) | .537 | 0.27 |
Insomnia Severity Index | 12.65 (6.50) | 10.60 (6.15) | .018 | 0.40 | 10.54 (6.73) | 12.00 (5.54) | .618 | −0.20 |
| Â | Prostate cancer group | |||||||
|  | Treatment group (N = 25) | Control group (N = 21) | ||||||
| Â | T0 | T1 | Evolution (T0-T1) | Effect size | T0 | T1 | Evolution (T0-T1) | Effect size |
|  | Mean (SD) | Mean (SD) | p | Cohen’s d | Mean (SD) | Mean (SD) | p | Cohen’s d |
HADS – Anxiety | 6.50 (3.06) | 4.88 (2.98) | .085 | 0.50 | 4.76 (3.59) | 5.71 (3.81) | .545 | −0.30 |
HADS - Depression | 3.46 (2.47) | 3.44 (2.89) | .992 | 0.01 | 4.19 (3.28) | 5.05 (4.85) | .516 | −0.29 |
EORTC – Global Health Status | 67.67 (14.30) | 69.33 (15.54) | .969 | −0.15 | 64.29 (20.94) | 65.48 (25.45) | .983 | −0.07 |
EORTC – Fatigue | 32.44 (12.39) | 34.22 (16.01) | .876 | −0.11 | 32.27 (27.87) | 29.63 (29.47) | .908 | 0.14 |
Insomnia Severity Index | 8.04 (5.98) | 6.92 (5.87) | .704 | 0.23 | 6.95 (5.13) | 5.86 (4.29) | .688 | 0.28 |